LONDON — Real-world, prospective, multicenter study results show high patient satisfaction with Bausch + Lomb’s enVista Aspire IOL, according to a presenter.
The lens was confirmed to offer enhanced depth of focus with no compromise on high-quality distance vision and minimal optical side effects.
“The strength of this study is that it included 57 different sites in the U.S., a wide variety of locations and multiple surgeons implanting the lens bilaterally in a total of 310 patients,” Cathleen M. McCabe, MD, said at the European Society of Cataract and Refractive Surgeons meeting.
The enVista